Cargando…

Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China

BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yazhuo, Li, Yingying, Shen, Hui, Li, Yike, Xu, Yanbing, Zhou, Mi, Xia, Xinghai, Shi, Binyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490461/
https://www.ncbi.nlm.nih.gov/pubmed/36157308
http://dx.doi.org/10.1177/20420188221118750
_version_ 1784793090179989504
author Liu, Yazhuo
Li, Yingying
Shen, Hui
Li, Yike
Xu, Yanbing
Zhou, Mi
Xia, Xinghai
Shi, Binyin
author_facet Liu, Yazhuo
Li, Yingying
Shen, Hui
Li, Yike
Xu, Yanbing
Zhou, Mi
Xia, Xinghai
Shi, Binyin
author_sort Liu, Yazhuo
collection PubMed
description BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academic researchers have for decades focused on the development of DN and recently found that free fatty acids (FFAs) constituted an independent risk factor for vascular complications in T2DM patients. It is therefore critical to determine whether the metabolic profile of FFAs is related to DN. METHODS: This study comprised 611 research subjects in Dalian, a city in northeast China: 52 DN patients, 115 T2DM patients, and 444 healthy controls. We determined 15 forms of serum FFAs, including arachidonic acid (AA, C20:4), docosahexaenoic acid (DHA, C22:6), erucic acid (C22:1), nervonic acid (NA, C24:1), estimated total omega-3s, total omega-6s, the omega-3/omega-6 ratio, and total FFA content by liquid chromatography–mass spectrometry (LC-MS). RESULTS: The levels of NA (mean = 45.27, range = 0.84–76.57) and DHA (mean = 324.58, range = 205.38–450.03) in DN patients were slightly lower than those in T2DM patients or healthy controls. The serum omega-3 polyunsaturated fatty acid (PUFA) DHA (C22:6) was significantly negatively correlated with microalbuminuria (MAU), the albumin/creatinine ratio (ACR), body mass index (BMI), fasting plasma glucose (FPG), and glycosylated hemoglobin (HbA1c). The serum monounsaturated fatty acid (MUFA) NA (C24:1) was significantly negatively correlated with BMI, FPG, and HbA1c. After adjustment of variables, multiple logistic regression analysis revealed significant odds ratios (ORs) [with confidence intervals (CIs)] for DHA (0.991, 0.985–0.997; p = 0.002) and NA (0.978, 0.958–0.999; p = 0.037). CONCLUSION: In this study, we ascertained that the contents of NA and DHA in patients with DN were relatively low, and that DHA was negatively correlated with MAU and the ACR. However, large-scale, population-based studies focusing on the role of NA and DHA in the pathogenesis of DN are still required in the future.
format Online
Article
Text
id pubmed-9490461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-94904612022-09-22 Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China Liu, Yazhuo Li, Yingying Shen, Hui Li, Yike Xu, Yanbing Zhou, Mi Xia, Xinghai Shi, Binyin Ther Adv Endocrinol Metab Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets BACKGROUND AND PURPOSE: With the progressive increase in the prevalence of type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN) – one of the most common chronic microvascular complications – has evolved into a significant cause of death worldwide among end-stage renal disease patients. Academic researchers have for decades focused on the development of DN and recently found that free fatty acids (FFAs) constituted an independent risk factor for vascular complications in T2DM patients. It is therefore critical to determine whether the metabolic profile of FFAs is related to DN. METHODS: This study comprised 611 research subjects in Dalian, a city in northeast China: 52 DN patients, 115 T2DM patients, and 444 healthy controls. We determined 15 forms of serum FFAs, including arachidonic acid (AA, C20:4), docosahexaenoic acid (DHA, C22:6), erucic acid (C22:1), nervonic acid (NA, C24:1), estimated total omega-3s, total omega-6s, the omega-3/omega-6 ratio, and total FFA content by liquid chromatography–mass spectrometry (LC-MS). RESULTS: The levels of NA (mean = 45.27, range = 0.84–76.57) and DHA (mean = 324.58, range = 205.38–450.03) in DN patients were slightly lower than those in T2DM patients or healthy controls. The serum omega-3 polyunsaturated fatty acid (PUFA) DHA (C22:6) was significantly negatively correlated with microalbuminuria (MAU), the albumin/creatinine ratio (ACR), body mass index (BMI), fasting plasma glucose (FPG), and glycosylated hemoglobin (HbA1c). The serum monounsaturated fatty acid (MUFA) NA (C24:1) was significantly negatively correlated with BMI, FPG, and HbA1c. After adjustment of variables, multiple logistic regression analysis revealed significant odds ratios (ORs) [with confidence intervals (CIs)] for DHA (0.991, 0.985–0.997; p = 0.002) and NA (0.978, 0.958–0.999; p = 0.037). CONCLUSION: In this study, we ascertained that the contents of NA and DHA in patients with DN were relatively low, and that DHA was negatively correlated with MAU and the ACR. However, large-scale, population-based studies focusing on the role of NA and DHA in the pathogenesis of DN are still required in the future. SAGE Publications 2022-09-16 /pmc/articles/PMC9490461/ /pubmed/36157308 http://dx.doi.org/10.1177/20420188221118750 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets
Liu, Yazhuo
Li, Yingying
Shen, Hui
Li, Yike
Xu, Yanbing
Zhou, Mi
Xia, Xinghai
Shi, Binyin
Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title_full Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title_fullStr Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title_full_unstemmed Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title_short Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China
title_sort association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern china
topic Diabetic Kidney Disease: Pathogenesis and Therapeutic Targets
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490461/
https://www.ncbi.nlm.nih.gov/pubmed/36157308
http://dx.doi.org/10.1177/20420188221118750
work_keys_str_mv AT liuyazhuo associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT liyingying associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT shenhui associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT liyike associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT xuyanbing associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT zhoumi associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT xiaxinghai associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina
AT shibinyin associationbetweenthemetabolicprofileofserumfattyacidsanddiabeticnephropathyastudyconductedinnortheasternchina